Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;4(6):324-37.
doi: 10.1002/psp4.41. Epub 2015 Jun 15.

A Tutorial on Target-Mediated Drug Disposition (TMDD) Models

Affiliations

A Tutorial on Target-Mediated Drug Disposition (TMDD) Models

P Dua et al. CPT Pharmacometrics Syst Pharmacol. 2015 Jun.

Abstract

Target-mediated drug disposition (TMDD) is the phenomenon in which a drug binds with high affinity to its pharmacological target site (such as a receptor) to such an extent that this affects its pharmacokinetic characteristics.1 The aim of this Tutorial is to provide an introductory guide to the mathematical aspects of TMDD models for pharmaceutical researchers. Examples of Berkeley Madonna2 code for some models discussed in this Tutorial are provided in the Supplementary Materials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart showing the development of TMDD models. References alongside arrows indicate who developed the model (example models are provided in Berkeley Madonna code in the Supplementary Material).
Figure 2
Figure 2
One-compartment TMDD model.
Figure 3
Figure 3
Two-compartment TMDD model, with binding in the central compartment.
Figure 4
Figure 4
Model with two drugs binding to the same target.
Figure 5
Figure 5
Two-compartment TMDD model with binding in both tissue and central compartments.
Figure 6
Figure 6
Flow chart showing the mathematical investigations completed on TMDD models in the current literature.

Similar articles

Cited by

References

    1. Levy G. Pharmacologic target-mediated drug disposition. Clin. Pharmacol. Ther. 1994;56:248–252. - PubMed
    1. Krause A. Lowe PJ. Visualization and communication of pharmacometric models with Berkeley Madonna. CPT Pharmacometrics Syst. Pharmacol. 2014;3:1–20. - PMC - PubMed
    1. Kenakin T. A Pharmacology Primer: Theory, Application, and Methods. San Diego & London: Elsevier Academic Press; 2004.
    1. Lauffenburger DA. Linderman JJ. Receptor: Models for Binding, Trafficking, and Signalling. New York: Oxford University Press; 1996.
    1. Wagner JG. Biopharmaceutics and Relevant Pharmacokinetics ( Fernandina Beach, FL: Drug Intelligence Publications, Hamilton Press; 1972.